Fidelity Investments
LENZ

Fidelity Investments’s LENZ Therapeutics LENZ Stock Holding History

Fidelity Investments’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.2M Sell
3,558,905
-38,879
-1% -$313K ﹤0.01% 1880
2026
Q1 		$32.9M Sell
3,597,784
-104,934
-3% -$1.47M ﹤0.01% 1585
2025
Q4 		$59.2M Buy
3,702,718
+3,615,405
+4,141% +$105M ﹤0.01% 1375
2025
Q3 		$4.07M Buy
87,313
+5,674
+7% +$209K ﹤0.01% 2309
2025
Q2 		$2.39M Buy
81,639
+500
+0.6% +$13.6K ﹤0.01% 2430
2025
Q1 		$2.09M Buy
81,139
+80,927
+38,173% +$1.99M ﹤0.01% 2431
2024
Q4 		$6.12K Buy
212
+78
+58% +$2.38K ﹤0.01% 4619
2024
Q3 		$3.18K Buy
134
+37
+38% +$821 ﹤0.01% 4715
2024
Q2 		$1.68K Sell
97
-1,276
-93% -$22.3K ﹤0.01% 4750
2024
Q1 		$30.7K Buy
1,373
+1,223
+815% +$25.4K ﹤0.01% 3818
2023
Q4 		$2.75K Buy
150
+36
+32% +$594 ﹤0.01% 4588
2023
Q3 		$1.99K Sell
114
-71
-38% -$1.24K ﹤0.01% 4540
2023
Q2 		$3.37K Buy
+185
New +$3.7K ﹤0.01% 4471
2023
Q1 		– Sell
-159,446
Closed -$3.71M – 5566
2022
Q4 		$3.71M Sell
159,446
-536,662
-77% -$12.4M ﹤0.01% 2198
2022
Q3 		$15.4M Sell
696,108
-50,672
-7% -$1.21M ﹤0.01% 1700
2022
Q2 		$14.4M Sell
746,780
-287,571
-28% -$6.41M ﹤0.01% 1792
2022
Q1 		$36.9M Buy
1,034,351
+141,824
+16% +$8.87M ﹤0.01% 1521
2021
Q4 		$77.7M Sell
892,527
-274
-0% -$22.7K 0.01% 1225
2021
Q3 		$101M Buy
892,801
+355,375
+66% +$52.6M 0.01% 1105
2021
Q2 		$111M Buy
+537,426
New +$93.6M 0.01% 1082

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

Fidelity Investments's LENZ Position: Q2 2026 in Review

Fidelity Investments reduced its LENZ Therapeutics (LENZ) stake by 1.1% in Q2 2026, selling an estimated $313K and leaving 3,558,905 shares worth $20.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1880.

Fidelity Investments first reported a position in LENZ in Q2 2021 and has held it in 20 quarters since. The position peaked at $111M in Q2 2021. 144 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Fidelity Investments held 3,558,905 shares of LENZ Therapeutics worth $20.2M as of Q2 2026.
  • Fidelity Investments sold 38,879 LENZ Therapeutics shares in Q2 2026, an estimated $313K.
  • LENZ Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #1880 holding.
  • Fidelity Investments first reported a position in LENZ Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Fidelity Investments's LENZ Therapeutics position peaked at $111M in Q2 2021.
  • 144 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.